2017 - CIRTA


This page contains exclusive content for the member of the following sections: TTS, ITA. Log in to view.

4a- Animal Models of Intestinal Failure/Regeneration

30.5 - Citrulline does not distinguish intestinal adaptation in neonatal piglet models of short bowel syndrome

Presenter: Marihan, Lansing, Leduc, Canada
Authors: Marihan Lansing, Justine Turner, Pamela Wizzard, Celeste Lavallee, David Lim, Mitsuru Muto, Patrick Nation, Paul Pencharz, Ronald Ball, Paul Wales

Citrulline does not distinguish intestinal adaptation in neonatal piglet models of short bowel syndrome

Marihan Lansing1, Justine M. Turner1, Pamela Wizzard1, Celeste Lavallee1, David W. Lim2, Mitsuru Muto3, Patrick N. Nation4, Paul B. Pencharz5, Ronald O. Ball6, Paul W. Wales7.

1 Pediatrics Gastroenterology and Nutrition, University of Alberta, Edmonton, AB, Canada; 2Surgery, University of Alberta, Edmonton, AB, Canada; 3Department of Pediatric Surgery, Kagoshima University, Sakuragaoka Kagoshima, Japan; 4Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada; 5Division of General and Thoracic Surgery, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada; 6Department of Agricultural, Life & Environmental Sciences, University of Alberta, Edmonton, AB, Canada; 7Pediatric Surgery, Hospital for Sick Children and Research Institute, University of Toronto, Toronto, ON, Canada

Background: Premature infants are at risk of intestinal failure, most often due to necrotizing enterocolitis and short bowel syndrome (SBS). Parenteral nutrition (PN) is essential for these infants, however, is complicated by sepsis and liver disease and is costly. Therefore, early enteral autonomy, through intestinal adaptation, is critical. Currently, there are no direct in vivo methods to measure adaptation in babies on PN. Plasma citrulline (CIT) is a proposed biomarker for adaptation, due to its correlation with intestinal length. Our aim was to evaluate the utility of CIT relative to the histological gold standard measure of adaptation, jejunal villus length. We evaluated two SBS anatomical subtypes: a mid-intestinal resection with jejunoileal anastomosis, and a distal resection of the ileum and ileocecal valve, which in our experience exhibits minimal adaptation.

Methods: Neonatal piglets (2-4d) were randomly allocated to either: 75% mid small intestinal resection (jejunoileal/JI, n= 5), 75% distal small intestinal resection (jejunocolic/JC, n=9), or sham control (n=8). A jugular catheter was inserted for PN and a gastric tube for trophic enteral nutrition. At laparotomy day 7, small intestine length and weight were measured, followed by jejunal tissue collection for blinded histopathological assessment of villus height and crypt depth. Baseline and terminal plasma CIT were measured using DC/LC-MS. Statistical analysis included independent t tests, one-way ANOVA, and linear regression.

Results: Amongst all piglets, mean CIT declined from baseline; sham (-42 %), JI (-64%) and JC (-58%). Day 7 CIT correlated with intestinal length (R2=0.34; p=0.003) and mucosal mass (R2=0.34; p=0.003). For SBS piglets alone, CIT did not correlate with intestinal length (p=0.7), mucosal mass (p=0.8) or jejunal villus height (p= 0.9). JI compared to JC piglets demonstrated an increase in small intestinal length (+18.3 vs -15.9cm; p<0.001) and greater mucosal mass (187.2 vs 153.5mg/cm; p=0.03). However, CIT did not differ between the SBS groups (729.0 vs 785.9pM; p=0.6).

Conclusion: In neonatal piglets plasma citrulline levels correlate with large differences in small intestinal length, and hence ‘identify’ SBS. However, citrulline did not discriminate between JI and JC surgical anatomy and failed to identify adaptive changes that were occurring in JI animals. Therefore, in this preclinical model of SBS, citrulline was not a useful biomarker of intestinal adaptation.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada